FDA: Recalled catheters pose serious safety risk; compounded drug recalled
Cordis Corporation recently recalled 25,000 catheters used to visualize and measure parts of the vascular system, due to the potential for their marker bands to move or dislodge during procedures. The Food and Drug Administration has identified this as a Class I recall due to the potential for serious injury or death.
In other news, IntegraDose Compounding Services this week recalled certain lots of Cefazolin for injection, an intravenous antibiotic, due to a lack of sterility assurance. The lots were recently distributed to U.S. hospitals, which should immediately quarantine the product for return to the company.
Related News Articles
Headline
Philips Respironics has recalled more than 17 million masks used with Bilevel Positive Airway Pressure and Continuous Positive Airway Pressure machines because…
Headline
The Food and Drug Administration today announced a Class 1 recall of devices used to access blood vessels through a patient’s bone because the devices may…
Headline
The Environmental Protection Agency today released a list of commercial medical device sterilizing facilities where lifetime risk from ethylene oxide emissions…
Headline
Baxter Healthcare Corp. recently recalled its Abacus software for ordering compounded liquid medications due to a risk the printed bag labels may contain…
Headline
Smiths Medical recently recalled more than 118,000 Medfusion syringe infusion pumps whose software could malfunction, causing serious patient harm or death,…
Headline
The Food and Drug Administration yesterday released an update on Medtronic’s recall of 1,614 devices used to pump blood from the heart to the rest of the…